References
- The Korean Movement Disorder Society. Report to expand the policy supporting Parkinson's disease in Korea. Seoul: 2007.
- Health Insurance Review and Assessment Service. Disease subclass statistics. Number of patients by year: Parkinson's disease. Available from: http://opendata.hira.or.kr/op/opc/olap3thDsInfo.do [accessed Oct 10, 2020]
- Kim JH. Analysis of prescription of Parkinson's drug using HIRA-NPS data. Master s' thesis, Graduate School of Sungkyunkwan University 2020.
- Lee JJ. Pharmacological treatment in Parkinson's disease. J Korean Neurol Assoc 2019;37(4):335-44. doi: 10.17340/jkna.2019.4.1
- Guideline center for Korean Medicine. Korean medicine clinical practice guideline for Parkinson's disease. Seoul: 2017. Available from: http://www.nckm.or.kr [accessed Oct 10, 2020]
- Cho KH. Korean medicine treatment of Parkinson's disease. Paju: Mulgogisup; 2018, p. 123-6.
- Lee SH, Lim S. Clinical effectiveness of acupuncture on Parkinson disease: A PRISMA-compliant systematic review and meta-analysis. Medicine 2017;96(3):e5836. doi: 10.1097/MD.0000000000005836
- Doo KH, Lee JH, Cho SY, Jung WS, Moon SK, Park JM, et al. A prospective open-label study of combined treatment for idiopathic Parkinson's disease using acupuncture and bee venom acupuncture as an adjunctive treatment. J Altern Complement Med 2015;21(10):598-603. doi: 10.1089/acm.2015.0078
- Hartmann A, Mullner J, Meier N, Hesekamp H, van Meerbeeck P, Habert MO, et al. Bee venom for the treatment of Parkinson disease - A randomized controlled clinical trial. PLoS One 2016;11(7):e0158235. doi: 10.1371/journal.pone.0158235
- Yang SB, KIm YJ, Lee HM, Lee SH, cho SY, Park JM, et al. Effects of korean medicine on postural instability and gait difficulty in patient with Parkinsonism: Retrospective Study. J Korean Med 2017;38(3):96-102. doi: 10.13048/jkm.17028
- Raha S, Dutta D, Roy A, Pahan K. Reduction of Lewy body pathology by oral cinnamon. J Neuroimmune Pharmacol 2020. doi: 10.1007/s11481-020-09955-2
- Ramazani E, YazdFazeli M, Emami SA, Mohtashami L, Javadi B, Asili J, et al. Protective effects of Cinnamomum verum, Cinnamomum cassia and cinnamaldehyde against 6-OHDA-induced apoptosis in PC12 cells. Mol Biol Rep 2020;47(4):2437-45. doi: 10.1007/s11033-020-05284-y
- Patel D, Jana A, Roy A, Pahan K. Cinnamon and its metabolite protect the nigrostriatum in a mouse model of Parkinson's disease via astrocytic GDNF. J Neuroimmune Pharmacol 2019;14(3):503-18. doi: 10.1007/s11481-019-09855-0
- Prorok T, Jana M, Patel D, Pahan K. Cinnamic acid protects the nigrostriatum in a mouse model of Parkinson's disease via Peroxisome Proliferator-Activated Receptorα. Neurochem Res 2019;44(4):751-62. doi: 10.1007/s11064-018-02705-0
- Maiolo SA, Fan P, Bobrovskaya L. Bioactive constituents from cinnamon, hemp seed and polygonum cuspidatum protect against H2O2 but not rotenone toxicity in a cellular model of Parkinson's disease. J Tradit Complement Med 2018;8(3):420-7. doi: 10.1016/j.jtcme.2017.11.001
- Bae WY, Choi JS, Jeong JW. The neuroprotective effects of cinnamic aldehyde in an MPTP mouse model of Parkinson's disease. Int J Mol Sci 2018;19(2):551. doi: 10.3390/ijms19020551.
- Zeng H, He G, Huang H, Li Y. Protective effect of total flavonoids of Cinnamomi cortex on PC12 cell injured by 6-Hydroxydopamine. Zhong Yao Cai 2017;40(12):2936-40. doi: 10.13863/j.issn1001-4454.2017.12.043
- Khasnavis S, Pahan K. Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease. J Neuroimmune Pharmacol 2014;9(4):569-81. doi: 10.1007/s11481-014-9552-2
- Shaltiel-Karyo R, Davidi D, Frenkel-Pinter M, Ovadia M, Segal D, Gazit E. Differential inhibition of α-synuclein oligomeric and fibrillar assembly in Parkinson's disease model by cinnamon extract. Biochim Biophys Acta 2012;1820(10):1628-35. doi: 10.1016/j.bbagen.2012.04.021
- Khasnavis S, Pahan K. Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons. J Neuroimmune Pharmacol 2012;7(2):424-35. doi: 10.1007/s11481-011-9286-3
- Brahmachari S, Jana A, Pahan K. Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol 2009;183(9):5917-27. doi: 10.4049/jimmunol.0803336
- de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol 2006;5(6):525-35. doi: 10.1016/S1474-4422(06)70471-9
- Korean medicine pharmacology Compilation committee. Korean medicine pharmacology. 4th ed. Seoul: Shinilbooks; 2015, p. 150-7.
- Ranasinghe P, Pigera S, Premakumara GAS, Galappaththy P, Constantine GR, Katulanda P. Medicinal properties of 'true' cinnamon (Cinnamomum zeylanicum): a systematic review. BMC Complement Altern Med 2013;13(1):275 doi: 10.1186/1472-6882-13-275
- Neuberger JM, Schweitzer S, Rolland M, Burghard R. Effect of sodium benzoate in the treatment of atypical nonketotic hyperglycinaemia. J Inherit Metab Dis 2000;23(1):22-6. doi: 10.1023/a:1005642728513
- Leonard JV, Morris AA. Urea cycle disorders. Semin Neonatol 2002;7(1):27-35. doi: 10.1053/siny.2001.0085
- What is sodium benzoate? Everything you need to know. Healthline. last modified Jan 21, 2019. Available from: https://www.healthline.com/nutrition/sodium-benzoate [accessed Nov 12, 2020]
- CREB. Wikipedia. Available from: https://en.wikipedia.org/wiki/CREB [accessed Oct 11, 2020]
- Yoon MJ, Lee HH. The physiological function of PPARα. Biochemistry and Molecular Biology News 2004;24(1):22-31.
- Ministry of Food and Drug Safety. Integrated pharmaceutical information system: Cinnamon Bark. Available from: https://nedrug.mfds.go.kr/pbp/CCEKP14/selectEkpPopupList [accessed Oct 11, 2020]
- Choe JG. Research on the coumarin analysis in the cinnamon contained foods for standardization & specification. Korea Food & Drug Administration 2009.